Study (year) | Present study (2019) | Lin et al. [19] | Xiang-yu et al. [15] | Lihteh et al. [26] | Oshima et al. [2] | Parolini et al. [18] |
---|---|---|---|---|---|---|
Period of study (number of years) | 2005–2017 (13) | 2011–2014 (4) | 2002–2012 (11) | 2005–2009 (5) | 2003–2008 (6) | 2003–2008 (6) |
No. of cases per patients (incidence rate) | 8/9102 (0.09) | 3/3979 (0.08) | 0/632 (0) | 3/10,845 (0.03) | 2/6660 (0.03) | 0/943 (0) |
No. of cases with postoperative hypotony (%) | 0 | NA | – | NA | 0 | – |
Intraoperative injections (number of infected eyes receiving injections) | 0 | NA | – | SC antibioticsa (2/3) | NA | – |
Median onset of endophthalmitis (days) | 5 (1–6) | 2 (1–5) | – | 3 (2–3) | 1.5 (1–2) | – |
No. of cases with culture-positive (%) | 4/8 (50) | 2/3 (67) | – | 2/3 (67) | 2/2 (100) | – |
Causative Microorganisms (%) | SL, EF, PM, AF | SE, ES | – | SE, SA | ES, MSSA | – |